In an 84-year-old man being evaluated for delayed or reduced ejaculation, does losartan affect ejaculation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Losartan Does Not Cause Delayed or Reduced Ejaculation

Losartan is not associated with ejaculatory dysfunction and may actually improve sexual function in hypertensive men. In fact, among antihypertensive medications, losartan appears to have a favorable sexual side effect profile compared to other drug classes.

Evidence from FDA Labeling and Clinical Studies

The FDA drug label for losartan does not list ejaculatory dysfunction, delayed ejaculation, or any sexual dysfunction as an adverse effect 1. This is significant because the FDA label comprehensively documents known adverse effects from clinical trials and post-marketing surveillance.

Clinical research demonstrates that losartan may actually improve sexual function rather than impair it. A prospective study of 82 hypertensive men with pre-existing sexual dysfunction showed that 12 weeks of losartan therapy (50-100 mg/day) improved sexual satisfaction from 7.3% to 58.5%, and subjects reporting high frequency of sexual activity increased from 40.5% to 62.3% 2. Importantly, 73.7% of subjects reported improved quality of life with losartan treatment.

Animal studies support these clinical findings. In spontaneously hypertensive rats, losartan preserved erectile function and showed no significant impairment of sexual performance after 7 and 30 days of treatment 3. Even after 90 days, only a minor increase in mount latency was observed in hypertensive rats, with no effect in normotensive animals. This contrasts sharply with propranolol (a beta-blocker), which significantly impaired multiple parameters of sexual function 3.

Mechanism: Losartan May Protect Sexual Function

Losartan appears to have protective effects on erectile tissue through suppression of apoptosis and fibrosis in the corpus cavernosum 4. In diabetic rats, losartan greatly improved corporal veno-occlusive dysfunction and reduced fibrosis through inhibition of the TGF-β1 pathway, effects that were superior to sildenafil alone 4.

Alternative Causes to Investigate in This 84-Year-Old Patient

Since losartan is not the culprit, you should systematically evaluate other causes of delayed ejaculation in this elderly patient:

Medication Review

  • Antidepressants (especially SSRIs) are strongly associated with delayed ejaculation 5, 6
  • Alpha-adrenergic blockers (commonly used for benign prostatic hyperplasia) are associated with ejaculatory dysfunction 6
  • Other antihypertensives, particularly beta-blockers and thiazide diuretics, can impair sexual function 2, 3

Medical Conditions to Assess

According to recent data mining studies, conditions associated with delayed ejaculation include 6:

  • Testicular dysfunction and male infertility
  • Anxiety disorders and psychoses
  • Disorders of lipid metabolism
  • Anemia
  • Diabetes (which can cause neuropathy affecting ejaculation)

Age-Related Factors

At 84 years old, this patient faces normal age-related decline in sexual function. The AUA/SMSNA guidelines note that ejaculatory dysfunction becomes increasingly common with age, associated with declining testosterone levels 5.

Recommended Evaluation Approach

  1. Obtain morning testosterone level - Low testosterone is associated with delayed ejaculation and should be replaced if deficient 5

  2. Review all medications systematically - Consider dose adjustment, replacement, or staged cessation of any medications that may contribute to delayed ejaculation 5

  3. Assess for comorbid erectile dysfunction - If ED precedes DE, treat the ED first as per AUA guidelines, as ED can secondarily cause ejaculatory difficulties 5

  4. Screen for diabetes, neuropathy, and vascular disease - Basic metabolic panel, lipids, and HbA1c may identify conditions predisposing to sexual dysfunction 5

Clinical Pitfall to Avoid

Do not discontinue or switch losartan based on concerns about ejaculatory dysfunction. Losartan is one of the few antihypertensive agents with evidence of improving rather than impairing sexual function 2. Switching to alternative antihypertensives (particularly beta-blockers or thiazides) could actually worsen sexual dysfunction while potentially destabilizing blood pressure control in this elderly patient.

The delayed ejaculation in this 84-year-old man warrants investigation of other medications, testosterone status, comorbid conditions, and age-related factors—but losartan should remain on his medication list.

References

Research

Sexual dysfunction in hypertensive patients treated with losartan.

The American journal of the medical sciences, 2001

Research

Losartan Preserves Erectile Function by Suppression of Apoptosis and Fibrosis of Corpus Cavernosum and Corporal Veno-Occlusive Dysfunction in Diabetic Rats.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017

Guideline

disorders of ejaculation: an aua/smsna guideline.

The Journal of urology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.